Long before he found himself in the middle of a multibillion-dollar takeover battle for a coveted new weight-loss drug, Whit ...

The new offer improves upon Pfizer’s earlier proposal for US$86.20 (RM359.97) a share including milestone payments, said the ...

NEW YORK/LONDON (Reuters) -A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker ...

President Donald Trump hailed his deal to slash the price of blockbuster weight loss drugs as a game changer, promising to ...

"Trump's meltdown unfolds as a fiery clapback rattles him to the core, leading to a desperate attempt to salvage his dignity, only to ...

The Centers for Medicare & Medicaid Services (CMS) late last week announced the creation of the GENErating cost Reductions for US (GENEROUS) Medicaid Model, which will utilize most-favored nation ...

Learn more about whether BioMarin Pharmaceutical Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A viral video circulated online in November 2025 that purported to show the United States Secretary of the Department of ...

Find insight on Eli Lilly, Novo Nordisk, AstraZeneca, Hikma Pharmaceuticals in the latest Market Talks covering the Health ...

As the executives took turns congratulating themselves, Findlay, who was standing in the back, began to wobble. David Ricks, Eli Lilly's CEO, was giving remarks at the time when he looked to his right ...

The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...